147 related articles for article (PubMed ID: 32057688)
1. Impact of Detecting Occult Pathologic Nodal Disease During Resection for Malignant Pleural Mesothelioma.
Verma V; Wegner RE; Stahl JM; Barsky AR; Raghavan D; Busquets TE; Hoppe BS; Grover S; Friedberg JS; Simone CB
Clin Lung Cancer; 2020 Jul; 21(4):e274-e285. PubMed ID: 32057688
[TBL] [Abstract][Full Text] [Related]
2. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
Mineo TC; Ambrogi V; Pompeo E; Baldi A; Stella F; Aurea P; Marino M
Ann Thorac Surg; 2008 May; 85(5):1740-6. PubMed ID: 18442576
[TBL] [Abstract][Full Text] [Related]
3. Management of Clinically Lymph Node-Positive Malignant Pleural Mesothelioma.
Verma V; Wegner RE; Adeberg S; Horne ZD; Grover S; Friedberg JS; Simone CB
Semin Thorac Cardiovasc Surg; 2020 Winter; 32(4):1125-1132. PubMed ID: 31226401
[TBL] [Abstract][Full Text] [Related]
4. Lymph node involvement and metastatic lymph node ratio influence the survival of malignant pleural mesothelioma: a French multicenter retrospective study.
Hysi I; Le Pimpec-Barthes F; Alifano M; Venissac N; Mouroux J; Regnard JF; Riquet M; Porte H
Oncol Rep; 2014 Jan; 31(1):415-21. PubMed ID: 24142233
[TBL] [Abstract][Full Text] [Related]
5. The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma.
Nakas A; Waller D; Lau K; Richards C; Muller S
Eur J Cardiothorac Surg; 2012 Jul; 42(1):72-6; discussion 76. PubMed ID: 22290929
[TBL] [Abstract][Full Text] [Related]
6. The impact of lymph node station on survival in 348 patients with surgically resected malignant pleural mesothelioma: implications for revision of the American Joint Committee on Cancer staging system.
Flores RM; Routledge T; Seshan VE; Dycoco J; Zakowski M; Hirth Y; Rusch VW
J Thorac Cardiovasc Surg; 2008 Sep; 136(3):605-10. PubMed ID: 18805259
[TBL] [Abstract][Full Text] [Related]
7. The IASLC Mesothelioma Staging Project: Proposals for Revisions of the N Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Pleural Mesothelioma.
Rice D; Chansky K; Nowak A; Pass H; Kindler H; Shemanski L; Opitz I; Call S; Hasegawa S; Kernstine K; Atinkaya C; Rea F; Nafteux P; Rusch VW;
J Thorac Oncol; 2016 Dec; 11(12):2100-2111. PubMed ID: 27687964
[TBL] [Abstract][Full Text] [Related]
8. Does mediastinal lymph node involvement influence the surgical outcome in malign pleural mesothelioma?
Bedirhan MA; Seyrek Y; Yaran V; Sezen CB; Cansever L; Metin M
Acta Chir Belg; 2023 Oct; 123(5):517-524. PubMed ID: 35815370
[TBL] [Abstract][Full Text] [Related]
9. Survival by Histologic Subtype of Malignant Pleural Mesothelioma and the Impact of Surgical Resection on Overall Survival.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Shabason J; Sharma S; Culligan MJ; Grover S; Friedberg JS; Simone CB
Clin Lung Cancer; 2018 Nov; 19(6):e901-e912. PubMed ID: 30224273
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Pathologically Positive Lymph Nodes in the Clinically Negative Neck: An Analysis of 39,301 Patients with Papillary Thyroid Cancer.
Ruel E; Thomas S; Perkins JM; Roman SA; Sosa JA
Ann Surg Oncol; 2017 Jul; 24(7):1935-1942. PubMed ID: 28127652
[TBL] [Abstract][Full Text] [Related]
11. The importance of surgical staging in the treatment of malignant pleural mesothelioma.
Rusch VW; Venkatraman E
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):815-25; discussion 825-6. PubMed ID: 8614142
[TBL] [Abstract][Full Text] [Related]
12. Clinicopathologic Factors Associated With Occult Lymph Node Metastasis in Patients With Clinically Diagnosed N0 Lung Adenocarcinoma.
Moon Y; Kim KS; Lee KY; Sung SW; Kim YK; Park JK
Ann Thorac Surg; 2016 May; 101(5):1928-35. PubMed ID: 26952299
[TBL] [Abstract][Full Text] [Related]
13. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
14. Facility volume and postoperative outcomes for malignant pleural mesothelioma: A National Cancer Data Base analysis.
Verma V; Ahern CA; Berlind CG; Lindsay WD; Grover S; Culligan MJ; Friedberg JS; Simone CB
Lung Cancer; 2018 Jun; 120():7-13. PubMed ID: 29748018
[TBL] [Abstract][Full Text] [Related]
15. The pattern of lymph node involvement influences outcome after extrapleural pneumonectomy for malignant mesothelioma.
Edwards JG; Stewart DJ; Martin-Ucar A; Muller S; Richards C; Waller DA
J Thorac Cardiovasc Surg; 2006 May; 131(5):981-7. PubMed ID: 16678579
[TBL] [Abstract][Full Text] [Related]
16. Reassessing the current TNM lymph node staging for renal cell carcinoma.
Terrone C; Cracco C; Porpiglia F; Bollito E; Scoffone C; Poggio M; Berruti A; Ragni F; Cossu M; Scarpa RM; Rossetti SR
Eur Urol; 2006 Feb; 49(2):324-31. PubMed ID: 16386352
[TBL] [Abstract][Full Text] [Related]
17. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study.
Ecker BL; McMillan MT; Datta J; Dempsey DT; Karakousis GC; Fraker DL; Drebin JA; Mamtani R; Giantonio BJ; Roses RE
Eur J Cancer; 2016 Dec; 69():135-141. PubMed ID: 27821316
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Nodal Upstaging in Clinical Node Negative Patients With Penile Carcinoma: A National Cancer Database Analysis.
Winters BR; Mossanen M; Holt SK; Lin DW; Wright JL
Urology; 2016 Oct; 96():29-34. PubMed ID: 27450944
[TBL] [Abstract][Full Text] [Related]
19. A proposal for combination of total number and anatomical location of involved lymph nodes for nodal classification in non-small cell lung cancer.
Saji H; Tsuboi M; Shimada Y; Kato Y; Yoshida K; Nomura M; Matsubayashi J; Nagao T; Kakihana M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Chest; 2013 Jun; 143(6):1618-1625. PubMed ID: 23740149
[TBL] [Abstract][Full Text] [Related]
20. The Role of Neoadjuvant Chemotherapy in Patients With Resectable Malignant Pleural Mesothelioma-An Institutional and National Analysis.
Voigt SL; Raman V; Jawitz OK; Bishawi M; Yang CJ; Tong BC; D'Amico TA; Harpole DH
J Natl Cancer Inst; 2020 Nov; 112(11):1118-1127. PubMed ID: 32011691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
